Memorial Sloan Kettering pediatric surgeon J. Ted Gerstle

J. Ted Gerstle, MD

Pediatric Surgical Oncologist


Chief, Pediatric Surgical Service

Clinical Expertise

Pediatric Solid Tumors; Wilms' Tumor; Neuroblastoma; Sarcomas; Primitive Neuroectodermal Tumors; Ovarian and Testicular Tumors; Kidney Cancers; Hepatic Tumors; Chest Wall and Lung Cancers; Lipoblastoma; Melanoma; Pancreatic Tumors

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Gerstle accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me


MD, Dartmouth Medical School


General Surgery – Pennsylvania State University


Pediatric General Surgery – University of Toronto, The Hospital for Sick Children

Board Certifications

Surgery (USA and Canada); Pediatric Surgery

I am a pediatric surgeon and Chief of the Pediatric Surgical Service at Memorial Sloan Kettering. I have dedicated my life to caring for children, particularly those with cancer. I take care of children and teenagers with many types of tumors and malignancies, and perform about 200 surgeries each year.

I have been a pediatric surgeon for nearly two decades. In those years, I have developed new methods to make surgical procedures more predictable and straightforward for various cancers. I prefer a team approach in the operating room. Working with a group of highly skilled surgeons, anesthesiologists, nurses, and other experts allows for the best possible outcomes.

I am very excited to continue my research in high-intensity focused ultrasound (HIFU) at MSK. This noninvasive procedure uses sound waves to pinpoint a tumor and destroy it. HIFU has the potential to offer another treatment option for children who have tumors that cannot be removed through surgery. My hope is that in time, fewer children will need surgery. This treatment could reduce surgical complications and improve overall survival, especially for children whose cancers have returned.

When I meet a child with cancer, I aim to present the situation and how we are going to approach it as clearly as possible. Families deserve a considerable amount of time to digest all the new information coming their way. I am happy to speak with them as many times as it takes for everyone to understand the plan and feel confident about it. And when a child is old enough to understand what is going on, it is important to involve them in the decision-making as much as possible. I recognize the tremendous level of trust that families place in us. It is very important to me that everyone feels comfortable and that they feel that they are in the best of hands.

Awards and Honors

  • Chief Surgical Residents’ Award for the Best Teacher, Division of General and Thoracic Surgery, Department of Surgery, Faculty of Medicine, The Hospital for Sick Children, University of Toronto, Canada (2018)


Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

Fahy A, Roberts A, Nasr A, Irwin M, Gerstle JT. Long term outcomes after concurrent ipsilateral nephrectomy versus kidney-sparing surgery for high-risk, intraabdominal neuroblastoma. Accepted for publication in the Journal of Pediatric Surgery. 2018.

Dziegielewski C, Contreras R, Weitzman S, Gerstle JT. Pediatric gastrointestinal post-transplant lymphoproliferative disorder: incidence, clinical features, and impact of surgical intervention on overall survival. Accepted for publication in the Journal of Pediatric Hematology and Oncology. 2018.

Fonseca A, Shaikh F, Ramphal R, Ng V, McGilvray I, Gerstle JT. Extreme hepatic resections for the treatment of advanced hepatoblastoma: are planned close margins an acceptable approach? Pediatr Blood Cancer. 2018 Feb; 65(2).

Kkolin D, Duan K, Ngan B, Gerstle JT, Kryzkanoska M, Somers G, Mete O. Expanding the spectrum of colonic manifestations in tuberous sclerosis: L-cell neuroendocrine tumor arising in the background of rectal pecoma. Endocrine Pathology. 2017 Jul 21.

Romao RL, Weber B, Gerstle JT, Grant R, Pippi Salle JL, Bägli DJ, Figueroa VH, Braga LH, Farhat WA, Koyle MA, Lorenzo AJ. Comparison between laparoscopic and open radical nephrectomy for the treatment of primary renal tumors in children: single-center experience over a 5-year period. J Pediatr Urol. 2014 Jun 1;10(3):488-94.

Rogers EM, Casadiego Cubides G, Lacy J, Gerstle JT, Kives S, Allen L. Preoperative risk stratification of adnexal masses: can we predict the optimal surgical management? J Pediatr Adolesc Gynecol. 2014 Jun 1;27(3):125-8.

Publications on PubMed

Visit PubMed for a full listing of Dr. Gerstle’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.